Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Chakrabarti 2019 MiP2019"

From Bioblast
(Created page with "{{Abstract |title=left|90px|Lisa Chakrabarti |info=MiP2019 |authors=Chakrabarti L |year=2019 |event=MiP2019 |abstract=Image:MITOEAGLE-logo.jp...")
 
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{Abstract
{{Abstract
|title=[[Image:Chakrabarti L.jpg|left|90px|Lisa Chakrabarti]]
|title=[[Image:Chakrabarti L.jpg|left|90px|Lisa Chakrabarti]] Levels of eicosanoids and cytokines reveal sex differences in cerebellar mitochondria in Parkinson’s disease and controls.
|info=[[MiP2019]]
|info=[[MiP2019]]
|authors=Chakrabarti L
|authors=Ingram TL, Ortori C, Shephard F, Barrett D, Chakrabarti L
|year=2019
|year=2019
|event=MiP2019
|event=MiP2019
|abstract=[[Image:MITOEAGLE-logo.jpg|left|100px|link=http://www.mitoglobal.org/index.php/MITOEAGLE|COST Action MitoEAGLE]]
|abstract=[[Image:MITOEAGLE-logo.jpg|left|100px|link=http://www.mitoglobal.org/index.php/MITOEAGLE|COST Action MitoEAGLE]]
At the request of the author, this abstract is not made available online.
|editor=[[Plangger M]], [[Tindle-Solomon L]]
|editor=[[Plangger M]], [[Tindle-Solomon L]]
}}
}}
{{Labeling}}
{{Labeling
|area=Comparative MiP;environmental MiP, Gender
|diseases=Parkinson's
|organism=Human
|tissues=Nervous system
}}
== Affiliations ==
::::Ingram TL(1), Ortori C(2), Shephard F(1), Barrett D(2), Chakrabarti L(1)
::::#SVMS
::::#School Pharmacy; Univ Nottingham, UK. - [email protected]
 
== References ==
::::#Currais A (2015) Ageing and inflammation - A central role for mitochondria in brain health and disease. Ageing Res Rev 21:30–42.
::::#Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 139:216-31.
::::#Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013) Risk factors for Parkinson’s disease may differ in men and women: an exploratory study. Horm Behav 63:308–14.

Latest revision as of 16:39, 1 October 2019

Lisa Chakrabarti
Levels of eicosanoids and cytokines reveal sex differences in cerebellar mitochondria in Parkinson’s disease and controls.

Link: MiP2019

Ingram TL, Ortori C, Shephard F, Barrett D, Chakrabarti L (2019)

Event: MiP2019

COST Action MitoEAGLE

At the request of the author, this abstract is not made available online.


Bioblast editor: Plangger M, Tindle-Solomon L


Labels: MiParea: Comparative MiP;environmental MiP, Gender  Pathology: Parkinson's 

Organism: Human  Tissue;cell: Nervous system 





Affiliations

Ingram TL(1), Ortori C(2), Shephard F(1), Barrett D(2), Chakrabarti L(1)
  1. SVMS
  2. School Pharmacy; Univ Nottingham, UK. - [email protected]

References

  1. Currais A (2015) Ageing and inflammation - A central role for mitochondria in brain health and disease. Ageing Res Rev 21:30–42.
  2. Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson’s disease. J Neurochem 139:216-31.
  3. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA (2013) Risk factors for Parkinson’s disease may differ in men and women: an exploratory study. Horm Behav 63:308–14.